Fronteratherapeutics
1 known investors
Frontera Therapeutics is a clinical-stage gene therapy company developing treatments for large-market and rare diseases across ophthalmology, cardiology, and neurology. Several of its programs, targeting conditions such as inherited retinal diseases, nAMD, and cardiomyopathies, have entered or completed Phase II clinical trials.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Fronteratherapeutics do?
- Frontera Therapeutics is a clinical-stage gene therapy company developing treatments for large-market and rare diseases across ophthalmology, cardiology, and neurology. Several of its programs, targeting conditions such as inherited retinal diseases, nAMD, and cardiomyopathies, have entered or completed Phase II clinical trials.
- Who are Fronteratherapeutics's investors?
- Fronteratherapeutics's investors include OrbiMed.